- Home
- JOF vs CADL Comparison
JOF vs CADL Comparison
Compare JOF & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOF
- CADL
- Stock Information
- Founded
- JOF 1990
- CADL 1999
- Country
- JOF Japan
- CADL United States
- Employees
- JOF N/A
- CADL N/A
- Industry
- JOF Trusts Except Educational Religious and Charitable
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- JOF Finance
- CADL Health Care
- Exchange
- JOF Nasdaq
- CADL Nasdaq
- Market Cap
- JOF 295.0M
- CADL 313.5M
- IPO Year
- JOF N/A
- CADL 2021
- Fundamental
- Price
- JOF $10.87
- CADL $4.67
- Analyst Decision
- JOF
- CADL Strong Buy
- Analyst Count
- JOF 0
- CADL 5
- Target Price
- JOF N/A
- CADL $19.80
- AVG Volume (30 Days)
- JOF 43.9K
- CADL 726.8K
- Earning Date
- JOF 01-01-0001
- CADL 11-13-2025
- Dividend Yield
- JOF 3.33%
- CADL N/A
- EPS Growth
- JOF N/A
- CADL N/A
- EPS
- JOF N/A
- CADL N/A
- Revenue
- JOF N/A
- CADL N/A
- Revenue This Year
- JOF N/A
- CADL N/A
- Revenue Next Year
- JOF N/A
- CADL N/A
- P/E Ratio
- JOF N/A
- CADL N/A
- Revenue Growth
- JOF N/A
- CADL N/A
- 52 Week Low
- JOF $6.64
- CADL $3.79
- 52 Week High
- JOF $8.04
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- JOF 64.70
- CADL 30.29
- Support Level
- JOF $10.78
- CADL $4.81
- Resistance Level
- JOF $10.98
- CADL $5.01
- Average True Range (ATR)
- JOF 0.11
- CADL 0.29
- MACD
- JOF -0.01
- CADL -0.08
- Stochastic Oscillator
- JOF 78.26
- CADL 0.00
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.